LatchBio’s Post

View organization page for LatchBio, graphic

5,520 followers

Oligonucleotide therapies are a rapidly advancing field of biotechnology that promise to cure previously undruggable diseases with small fragments of RNA. Leveraging advances in accessible computation to power ultra high-throughput experimentation, Elsie Biotechnologies is building a new platform for the design, testing, and validation of oligonucleotide therapeutics at an unprecedented scale. Learn about the mechanics of their platform and how their partnership with LatchBio has accelerated their science. Read out the full case study here: https://lnkd.in/g8eFuSti Have questions about Elsie or their science? Register for our webinar to ask Elsie's co-founder, Dillon Flood, directly. https://lnkd.in/gewrzxTG

  • No alternative text description for this image
tony blekaitis

self made man at my own

7mo

Wow

Like
Reply
Lucy Ma

PhD Candidate | Regen Med & Synbio | Space Med 🚀🧬 | Iron Dragons

8mo

Fascinating!! 👏

Very interesting 

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics